Kenvue said net sales for the 6 months ended June 29, 2025 were $7.6 billion, a decrease of $314 million, or 4.0%, compared with $7.9 billion in the prior-year period. The company cited volume-related decreases of 2.1% and unfavorable value realization of 0.6% as factors in the organic sales decline of 2.7%.

1. 01

   Kenvue said net sales for the 6 months ended June 29, 2025 were $7.6 billion, a decrease of $314 million, or 4.0%, compared with $7.9 billion in the prior-year period. The company cited volume-related decreases of 2.1% and unfavorable value realization of 0.6% as factors in the organic sales decline of 2.7%.

2. 02

   Kenvue said Skin Health and Beauty segment net sales for the 6 months were $2.0 billion, a decrease of $121 million, or 5.6%, and segment adjusted operating income decreased $70 million, or 22.5%, to $241 million. The company cited strategic price investments and volume-related decreases as factors in the organic sales decline.

3. 03

   Kenvue said net cash flows from operating activities for the 6 months were $1,049 million, an increase of $322 million compared with $727 million in the prior-year period. Net cash flows used in financing activities for the same period were $858 million, with the company citing dividend payments of $785 million and repayment of 5.50% Senior Notes due 2025 of $750 million as principal items.

4. 04

   Kenvue said cash and cash equivalents as of June 29, 2025 were $1,070 million and total debt was $8,610 million. The company issued senior unsecured notes maturing in 2032 on May 22, 2025 in an aggregate principal amount of $750 million.

Key figures

Quarter ended June 29, 2025

Revenue

$3.8B

Operating income

$692M

Net income

$420M

EPS

$0.22

Gross profit

$2.3B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.